DSM Launches New Omega-3 Technology for Customizable High-Concentrates
The new 3C technology allows for “tailored omega-3 EPA and DHA high concentrates,” according to DSM.
Photo © iStockphoto.com/numbeos
DSM (Parsippany, NJ) has unveiled a new omega-3 process technology that it says allows for “tailored omega-3 EPA and DHA high concentrates.” The new 3C technology, which is suitable for both dietary supplements and pharmaceutical applications, allows for omega-3 concentrates of up to 85% and customizable ratios of EPA and DHA.
DSM adds that the “radically efficient” technology is designed to make high-concentrate omega-3 ingredients more accessible than ever by giving brand owners more versatility to tailor their products to meet consumer needs. The firms says its 3C technology “will be a catalyst for category growth by helping to eliminate key barriers to consumption of omega-3 supplements, such as capsule size.”
“This new technology truly makes the oversized pills of traditional fish oil with low EPA and DHA omega-3 content a thing of the past,” says Tobe Cohen, vice president of DSM Nutritional Products. DSM’s new technology debuted at the recent SupplySide West trade show.
Read more:
Omega-3 Ingredient Innovation at SupplySide West
2016 Omega-3 Market Update: Fish Oil, Krill Oil, Astaxanthin, and More
Widespread Omega-3 Usage Could Save €12.9 Billion in Annual EU Healthcare Costs, Study Suggests
NutriSciences Innovations announces acquisition of XSTO Solutions
October 22nd 2024According to the company’s press release, the strategic acquisition adds six new branded products to the NutriScience portfolio, strengthening its role as a preferred ingredient supplier to leading brands in the wellness, food, and beverage industries.
